The Fosun-backed stroke-prevention technology developer received $14.1m in a round led by Hidea Venture Capital that will fund clinical testing for its devices.
Stroke Medical, a China-based medical device developer backed by conglomerate Fosun, has closed almost RMB100m ($14.1m) in funding, in a round led by investment firm Hidea Venture Capital.
Shengyu Investment and Grand Yangtze Capital also contributed to the round, which followed an undisclosed amount of series A funding from Fosun’s healthcare affiliate, Fosun Pharma, in November 2018 according to China Money Network.
Founded in 2016, Stroke Medical is working on minimally invasive devices that are intended to prevent and treat…
